FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Noven Pharmaceuticals Minivelle Recall

Minivelle (estradiol Transdermal System) 0

Noven Pharmaceuticals, Inc. · Miami, FL

Risk level
Class III
Reported by FDA
Jul 5, 2017
Recall ID
D-0923-2017
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Minivelle starting Apr 27, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0923-2017 on Jul 5, 2017. Reason: Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH. Status: Terminated.

Why it was recalled

Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

Product description

Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8

Lot numbers, UPCs & expiration codes

Lot #:: 78618, Exp. 05/2017

Where it was sold

Nationwide within US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0923-2017
Classification
Class III
Status
Terminated
Recall initiated
Apr 27, 2017
FDA report date
Jul 5, 2017
Quantity
14434 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0923-2017, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Terminated
Country
United States
Event ID
77466
Address
11960 SW 144th St
Code information
Lot #:: 78618, Exp. 05/2017
Postal code
33186-6109
Report date
Jul 5, 2017
Product type
Drugs
Recall number
D-0923-2017
Classification
Class III
Recalling firm
Noven Pharmaceuticals, Inc.
Product quantity
14434 cartons
Termination date
Mar 11, 2019
Reason for recall
Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8
Distribution pattern
Nationwide within US
Recall initiation date
Apr 27, 2017
Initial firm notification
Letter
Center classification date
Jun 23, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0923-2017, published Jul 5, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls